Burke Robert David 13D and 13G filings for Nascent Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-14 1:51 pm Purchase |
2023-04-14 | 13D | Nascent Biotech, Inc. NBIO |
Burke Robert David | 21,272,889 16.700% |
21,272,889 (New Position) |
Filing |